{
    "doi": "https://doi.org/10.1182/blood.V106.11.460.460",
    "article_title": "Retroviral Gene Therapy of RAG-1-/- Mice: Balance between Efficiency and Toxicity. ",
    "article_date": "November 16, 2005",
    "session_type": "Oral Sessions",
    "abstract_text": "Patients affected by severe combined immunodeficiency (SCID) have a profound defect in T cell development and the only curative treatment is hematopoietic stem cell transplantation (HSCT). When an HLA-identical family related donor exists, the success rate of HSCT is 90% while in all others cases, it ranges between 40 and 70%. In SCID patients also presenting B cell differentiation defects, such as in RAG-1 and RAG-2 deficiencies, the survival rate is significantly reduced. We have thus been interested in the development of a potential alternative treatment by using retroviral gene transfer of a normal copy of RAG-1 cDNA. To this end, murine RAG-1 deficient hematopoietic stem cells were transduced with a retroviral modified Moloney leukemia virus vector containing the RAG-1cDNA and transplanted into RAG-1-deficient mice. B and T cell development was achieved in all the recipient mice and the reconstitution is stable over time, attesting for a selective advantage of transduced progenitors. The T cell compartment was found to be diverse and functional as shown by Va and Vb TCR immunoscope analysis as well as proliferation assays in the presence of mitogens. The mature circulating B lymphocytes were not abundant but functional as the serum immunoglobulin levels and specific antibody response against the T cell dependent KLH antigen were always within normal range. Noteworthy, a high transgene copy number was detected in all lymphoid organs and this was associated with a risk of insertional mutagenesis as observed in one mouse. Altogether, these results demonstrate that RAG-1 gene transfer can correct immunodeficiency associated with RAG-1 defect but that human application would require the use of lentivirus vectors with self inactivating long terminal repeats in order to decrease the risk of lymphoproliferative diseases.",
    "topics": [
        "antigens",
        "dna, complementary",
        "gene therapy",
        "gene transfer techniques",
        "hematopoietic stem cell transplantation",
        "human leukocyte antigens",
        "immunoglobulins",
        "immunologic deficiency syndromes",
        "lymphoproliferative disorders",
        "mice"
    ],
    "author_names": [
        "Chantal Lagresle-Peyrou, PhD",
        "Frank Yates, PhD",
        "Michele Malassis-Seris",
        "Christophe Hue",
        "Estelle Morillon",
        "Alexandrine Garrigue",
        "Allen Liu, MD",
        "Philippe Hajdari",
        "Daniel Stockholm, PhD",
        "Olivier Danos, PhD",
        "Brigitte Lemercier",
        "Marie-Lize Gougeon, PhD",
        "Frederic Rieux-laucat, PhD",
        "Jean-Pierre de Villartay, PhD",
        "Alain Fischer, PU, PH",
        "Marina Cavazzana-Calvo, PU, PH"
    ],
    "author_dict_list": [
        {
            "author_name": "Chantal Lagresle-Peyrou, PhD",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Frank Yates, PhD",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Malassis-Seris",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christophe Hue",
            "author_affiliations": [
                "Department of Biotherapy, AP-HP, Hopital Necker-Enfants Malades, Paris, France"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Estelle Morillon",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alexandrine Garrigue",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Allen Liu, MD",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Philippe Hajdari",
            "author_affiliations": [
                "Centre National de la Recherche Scientifique, UMR 8115, Genethon, Evry, France"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniel Stockholm, PhD",
            "author_affiliations": [
                "Centre National de la Recherche Scientifique, UMR 8115, Genethon, Evry, France"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Olivier Danos, PhD",
            "author_affiliations": [
                "Centre National de la Recherche Scientifique, UMR 8115, Genethon, Evry, France"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Brigitte Lemercier",
            "author_affiliations": [
                "Immunite Anti-Virale, Biotherapie et Vaccins, Inserm U668, Institut Pasteur, Paris, France"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marie-Lize Gougeon, PhD",
            "author_affiliations": [
                "Immunite Anti-Virale, Biotherapie et Vaccins, Inserm U668, Institut Pasteur, Paris, France"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Frederic Rieux-laucat, PhD",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jean-Pierre de Villartay, PhD",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France",
                "Assistance Publique, Hopitaux de Paris (AP/HP), Paris, France"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alain Fischer, PU, PH",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France",
                "eUnite d\u2019Immunologie et d\u2019He\u0301matologie Pediatriques, AP/HP, Hopital Necker-Enfants Malades, Paris, France"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marina Cavazzana-Calvo, PU, PH",
            "author_affiliations": [
                "Inserm U429, Universite Paris-Descartes, Faculte de Medecine, Inserm U429, Site Necker-Enfants Malade, Paris, France",
                "Department of Biotherapy, AP-HP, Hopital Necker-Enfants Malades, Paris, France"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-28T13:06:54",
    "is_scraped": "1"
}